$IFRX Cashflow Statement | Understand Stock

$IFRX

$1.58 +$0.01 (0.96%) Close

Financial Statements

In millions of EUR, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Loss for the period
Adjustments for:
Depreciation & amortization of property and equipment, right-of-use assets and intangible assets
Net finance income
Share-based payment expense
Net foreign exchange differences
Other non-cash adjustments
Other assets

Changes in:
Other assets from government grants and research allowances
Other assets and trade receivables
Employee benefits
Other liabilities
Liabilities from government grants received
Trade and other payables
Inventories
Interest received
Interest paid
Net cash used in operating activities
Investing activities
Purchase of intangible assets and property and equipment
Purchase of current and non-current financial assets
Proceeds from sale of current financial assets
Net cash from/ (used in) investing activities
Financing activities
Proceeds from issuance of common shares
Transaction costs from issuance of common shares
Proceeds from issuance of ordinary shares
Proceeds from pre-funded warrants
Transaction costs from issuance of ordinary shares and pre-funded warrants
Proceeds from exercise of share options
Repayment of lease liabilities

Net cash from financing activities
Net in-/decrease in cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Comments